REVIVA PHARMACEUTICALS
Reviva Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing significant unmet medical needs and burden to society, patients, and their families. Reviva’s current pipeline focuses on the central nervous system, respiratory, and metabolic diseases. Reviva is using chemical genomics driven technology platform and proprietary chemistry to develop new medicines. Reviva’s pipeline currently has two drug candidates, RP5063 (Brilaroxazine) and RP1208. Both are new chemical entities discovered in-house. Reviva has been granted composition of matter patents for both RP5063 and R1208 in the United States (U.S.), Europe, and several other countries.
REVIVA PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Genetics Health Care Pharmaceutical
Founded:
2006-01-01
Address:
San Jose, California, United States
Country:
United States
Website Url:
http://www.revivapharma.com
Total Employee:
11+
Status:
Active
Contact:
+114088161470
Email Addresses:
[email protected]
Total Funding:
41.41 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API WordPress Apache Wordpress Plugins Microsoft Exchange Online IPv6 Cloudflare JS
Similar Organizations
Afferent Pharmaceuticals
Afferent Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines to treat chronic pain.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
American Family Care
American Family Care is a medical practice offering occupational health services.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Deciduous Therapeutics
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.
Eloxx
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.
Harbour Biomed
Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.
Imago Pharmaceuticals
Imago Pharmaceuticals is a virtual, privately held company developing JNK-directed novel therapies.
Jacobio Pharmaceuticals
Jacobio Pharmaceuticals is a clinical-stage pharmaceutical company focusing on the development of innovative oncology and other therapies.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
New River Pharmaceuticals Inc
New River Pharmaceuticals is a specialty pharmaceutical company developing novel pharmaceuticals.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Pacira Pharmaceuticals
Pacira Pharmaceuticals is a specialty pharmaceutical company dedicated to postsurgical innovation.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Xenon Pharmaceuticals
Xenon Pharmaceuticals operates as a neurology-focused biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.revivapharma.com Semrush global rank: 4.3 M Semrush visits lastest month: 2.67 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Reviva Pharmaceuticals"
Reviva Pharmaceuticals - Crunchbase Company Profile …
Contact Email [email protected] Phone Number +114088161470 Reviva Pharmaceuticals is a clinical-stage biopharmaceutical company that …See details»
Overview, News & Similar companies - ZoomInfo.com
Jul 9, 2024 Reviva Pharmaceuticals contact info: Phone number: (408) 501-8881 Website: www.revivapharma.com What does Reviva Pharmaceuticals do? Reviva Pharmaceuticals Inc …See details»
Reviva Pharmaceuticals - The Org
Reviva Pharmaceuticals, Inc., (Reviva) headquartered in Santa Clara, California, is a publicly traded, late-stage clinical development pharmaceutical company. Reviva is developing a …See details»
Company Description - Stock Analysis
May 19, 2025 10080 N. Wolfe Road, Suite SW3-200 Cupertino, California 95014 United StatesSee details»
Reviva Pharmaceuticals - Craft
Oct 29, 2024 Reviva Pharmaceuticals is a pharmaceutical company. It develops a portfolio of internally discovered therapies that address unmet medical needs in the areas of central …See details»
Reviva Pharmaceuticals Holdings, Inc. - PRISM MarketView
Reviva Pharmaceuticals Holdings, Inc. 19925 Stevens Creek Boulevard Suite 100 Cupertino, CA 95014 United StatesSee details»
Reviva Pharmaceuticals - LinkedIn
Https://revivapharma.com 32 Like Comment Share Reviva Pharmaceuticals 1,891 followers 2mo Report this post We recently reported financial results for the full year ended December 31, …See details»
Corporate Presentation - Reviva Pharmaceuticals
1 day ago Reviva Pharmaceuticals Holdings, Inc. 10080 N Wolfe Road, Suite SW3-200. Cupertino, CA 95014. Phone: +1.408.501.8881 Email: [email protected]See details»
Reviva Pharmaceuticals, Inc. Company Profile | Cupertino, CA ...
Find company research, competitor information, contact details & financial data for Reviva Pharmaceuticals, Inc. of Cupertino, CA. Get the latest business insights from Dun & Bradstreet.See details»
Reviva Pharmaceuticals Management Team | Org Chart
Reviva Pharmaceuticals employs 16 employees. The Reviva Pharmaceuticals management team includes Narayan Prabhu (Chief Financial Officer), Richard Margolin (Member, Board of …See details»
Reviva Pharmaceuticals Holdings, Inc. Receives FDA May
Jan 10, 2022 Reviva Pharmaceuticals Holdings, Inc. Receives FDA May Proceed Letter for Pivotal Phase 3 Clinical Trial and Long-Term Safety Trial Evaluating Brilaroxazine For The …See details»
Reviva Pharmaceuticals - VentureRadar
Website: http://www.revivapharma.com. Develops next-generation therapeutics targeting central nervous system, respiratory, and metabolic diseases, with a current ...See details»
Investors - Reviva Pharmaceuticals
3 days ago Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is a clinical-stage pharmaceutical company that discovers, develops and seeks to commercialize next …See details»
Reviva Pharmaceuticals Holdings Inc. - Cruelty Free Investing
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet …See details»
Reviva Announces Positive Preliminary Topline Data for the Long …
CUPERTINO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company …See details»
Governance - Reviva Pharmaceuticals
Reviva Pharmaceuticals Holdings, Inc. 10080 N Wolfe Road, Suite SW3-200. Cupertino, CA 95014. Phone: +1.408.501.8881 Email: [email protected]See details»
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed
1 day ago CUPERTINO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical …See details»
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public …
1 day ago CUPERTINO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical …See details»
About us - Reviva Pharmaceuticals
Our lead drug candidate, brilaroxazine, is in clinical development for multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder, major depressive disorder (MDD), …See details»
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public ...
2 days ago CUPERTINO, Calif., June 25, 2025 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage …See details»